Key terms

About TENX

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TENX news

Feb 24 10:06am ET Tenax Therapeutics Meets Nasdaq’s Float Requirement Compliance by TipRanks Feb 20 11:50am ET Tenax negotiates global levosimendan rights, says Roth MKM by TipRanks Feb 20 8:46am ET Tenax announces global license amendment, expands rights to levosimendan by TipRanks Feb 20 8:42am ET Tenax Therapeutics Amends Global Rights Deal with Orion by TipRanks Feb 12 5:04pm ET Tenax Therapeutics Raises $9M in Public Offering and Warrants by TipRanks Feb 09 11:12am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 08 11:40am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 08 8:20am ET Tenax Therapeutics prices 1.6M shares at $5.65 in public offering by TipRanks Feb 07 8:08pm ET Tenax Therapeutics enrolls first patient in Phase 3 study of TNX-103 by TipRanks Feb 07 9:36am ET Tenax Therapeutics trading resumes by TipRanks Feb 07 9:31am ET Tenax Therapeutics trading halted, volatility trading pause by TipRanks Feb 07 4:21am ET Tenax Therapeutics Granted Patent for Heart Treatment Drugs by TipRanks Feb 06 9:38am ET Tenax Therapeutics trading resumes by TipRanks Feb 06 9:33am ET Tenax Therapeutics trading halted, volatility trading pause by TipRanks Feb 06 8:42am ET Tenax announces USPTO grants notice of allowance for patent application by TipRanks Jan 02 7:50pm ET Tenax Therapeutics trading halted, news pending by TipRanks Dec 29 8:30am ET Tenax Therapeutics announces 1-for-80 reverse stock split by TipRanks

No recent news articles are available for TENX

No recent press releases are available for TENX

TENX Financials

1-year income & revenue

Key terms

TENX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TENX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’